Breast Cancer Research and Treatment

, Volume 79, Issue 3, pp 409–413

Polymorphisms in the Estrogen Receptor Beta Gene and Risk of Breast Cancer: No Association

  • Asta Försti
  • Chunyan Zhao
  • Elisabeth Israelsson
  • Karin Dahlman-Wright
  • Jan-Åke Gustafsson
  • Kari Hemminki
Article

Abstract

Polymorphisms in the estrogen receptor beta (ERβ) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERβ gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.

breast cancer estrogen receptor beta polymorphism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85, 2000 (see comments)Google Scholar
  2. 2.
    Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21: 1-18, 2001Google Scholar
  3. 3.
    Key TJ: Serum oestradiol and breast cancer risk. Endocr Relat Cancer 6: 175-180, 1999Google Scholar
  4. 4.
    White R, Parker MG: Molecular mechanisms of steroid hormone action. Endocr Relat Cancer 5: 1-14, 1998Google Scholar
  5. 5.
    Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996Google Scholar
  6. 6.
    Mosselman S, Polman J, Dijkema R: ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49-53, 1996Google Scholar
  7. 7.
    Rosenkranz K, Hinney A, Ziegler A, Hermann H, Fichter M, Mayer H, Siegfried W, Young JK, Remschmidt H, Hebebrand J: Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab 83: 4524-4527, 1998Google Scholar
  8. 8.
    Tsukamoto K, Inoue S, Hosoi T, Orimo H, Emi M: Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus. J Hum Genet 43: 73-74, 1998Google Scholar
  9. 9.
    Kumar R, Höglund L, Zhao C, Försti A, Snellman E, Hemminki K: Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer 103: 671-675, 2003Google Scholar
  10. 10.
    Försti A, Jin Q, Grzybowska E, Soderberg M, Zientek H, Sieminska M, Rogozinska-Szczepka J, Chmielik E, Utracka-Hutka B, Hemminki K: Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer. Carcinogenesis 23: 1315-1320, 2002Google Scholar
  11. 11.
    Försti A, Jin Q, Sundqvist L, Soderberg M, Hemminki K: Use of monozygotic twins in search for breast cancer susceptibility loci. Twin Res 4: 251-259, 2001Google Scholar
  12. 12.
    Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landen M, Jansson M, Holm G, Bjorntorp P, Eriksson E: Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86: 2562-2568, 2001Google Scholar
  13. 13.
    Peltonen L, Jalanko A, Varilo T: Molecular genetics of the Finnish disease heritage. Hum Mol Genet 8: 1913-1923, 1999Google Scholar
  14. 14.
    Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E: Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomark Prev 10: 1239-1248, 2001Google Scholar
  15. 15.
    Hemminki K, Försti A: Proper controls for SNP studies? Carcinogenesis 23: 1405, 2002Google Scholar
  16. 16.
    Sundarrajan C, Liao WX, Roy AC, Ng SC: Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 86: 135-139, 2001Google Scholar
  17. 17.
    Ogawa S, Hosoi T, Shiraki M, Orimo H, Emi M, Muramatsu M, Ouchi Y, Inoue S: Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 269: 537-541, 2000Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Asta Försti
    • 1
  • Chunyan Zhao
    • 1
  • Elisabeth Israelsson
    • 1
  • Karin Dahlman-Wright
    • 1
  • Jan-Åke Gustafsson
    • 1
  • Kari Hemminki
    • 1
  1. 1.Department of Biosciences at NovumKarolinska InstituteHuddinge

Personalised recommendations